Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011)

Integra Lifesciences Holdings' (IART) quarterly Land & Improvements came in at $2.7 million in Q4 2011, down 0.62% year-on-year from $2.7 million in Q4 2010, and down 0.62% quarter-over-quarter from $2.7 million in Q4 2010.

Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011) Analysis & Trends

Integra Lifesciences Holdings has disclosed Land & Improvements across 2 years of filings, most recently posting $2.7 million for Q4 2011.

  • Land & Improvements for Q4 2011 came in at $2.7 million, down 0.62% year-over-year; the trailing twelve-month figure through Dec 2011 was $2.7 million (down 0.62% YoY), and the FY2011 annual result was $2.7 million, down 0.62% from the prior year.
  • Land & Improvements came in at $2.7 million for Q4 2011 at Integra Lifesciences Holdings, down from $2.7 million in the prior quarter.
  • In the past five years, Land & Improvements ranged from a high of $2.7 million in Q4 2010 to a low of $2.7 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 1.80 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 188.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 112.30 Mn
10 Integra Lifesciences Holdings 1.37 Bn 1.10 Bn 216.98 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 2.71 Mn
Dec 31, 2010 2.73 Mn